Trevon Diggs' Cowboys Return Timeline Unclear
Dallas Cowboys star Trevon Diggs remains out with a concussion from a home accident and a knee issue. Find out Jerry Jones's update on his potential season return.
Category : Search result: Evangeline Lilly concussion
Giants' Jaxson Dart concussion recovery update
New York Giants quarterback Jaxson Dart progresses through concussion protocol. Will the 22-year-old star return against New England Patriots on December 1? Latest updates here.
Eli Lilly First Pharma to Reach $1 Trillion Market Cap
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
Alzheimer's Drug Donanemab Approved in India
Eli Lilly's Alzheimer's drug donanemab gets Indian regulatory approval. The treatment slows cognitive decline by 35.1% and could be available next year. Learn about its benefits and pricing.
Alzheimer's Drug Donanemab Approved for India
Eli Lilly's Alzheimer's drug donanemab gets Indian regulator nod. The treatment slows cognitive decline by 35.1% and is expected to launch in India next year. Details on pricing and safety.
Browns' QB Shakeup: Sanders In, Gabriel Out for Week 12
Cleveland Browns face a QB crisis as Dillon Gabriel enters concussion protocol. Rookie Shedeur Sanders is now the top option against the Raiders. Full details on the team's dramatic shift.
Novo Nordisk Cuts Wegovy Price, Eyes Oral Pill Launch
Novo Nordisk reduces Wegovy's price to $349 and prepares an aggressive launch for its oral weight-loss pill to combat competition from Eli Lilly and expand patient access.
UCLA QB Nico Iamaleava Out vs Ohio State
UCLA Bruins' starting quarterback Nico Iamaleava will miss the crucial game against Ohio State Buckeyes due to a concussion. Read how this impacts the team's bowl eligibility hopes.
Medicare Deal Slashes Obesity Drug Prices for Millions
Trump administration secures obesity drug price cuts with Eli Lilly and Novo Nordisk. Medicare coverage expansion opens 30 million patient market starting April 2026. Read analysis.
Trump: Deal Reached to Lower Weight Loss Drug Prices
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
Big Pharma Cuts Obesity Drug Prices After Trump Pressure
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
Eli Lilly's Diabetes & Weight Loss Pill Replaces Injections
Eli Lilly is developing Orforglipron oral pills for weight loss and type 2 diabetes that could replace injections, making treatment more accessible and convenient for millions.
Eli Lilly Ups Forecast as Zepbound Demand Soars
Pharmaceutical giant Eli Lilly raises full-year profit forecast as demand skyrockets for revolutionary weight-loss treatment Zepbound, sending shares climbing 7%.
Eli Lilly & NVIDIA Partner for AI Drug Discovery
Pharmaceutical giant Eli Lilly partners with NVIDIA to deploy cutting-edge AI supercomputers that will accelerate drug development and transform pharmaceutical research.
Cipla Shares Fall 3% Despite Eli Lilly Weight Loss Drug Deal
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Lilly-Cipla Partnership Expands Weight Loss Therapy Access
In a groundbreaking move, Eli Lilly partners with Cipla to dramatically expand availability of innovative weight loss therapies across India, addressing the growing obesity crisis.
Cipla-Eli Lilly deal brings weight loss drugs to India
Indian pharmaceutical giant Cipla announces landmark deal with Eli Lilly to manufacture and distribute popular weight loss medications Mounjaro and Zepbound in India under different brand names.
Eli Lilly-Cipla Partner for Weight Loss Drugs in India
Pharma giant Eli Lilly collaborates with Indian partner Cipla to introduce groundbreaking obesity and diabetes treatments Mounjaro and Yurpeak in the Indian market, expanding access to innovative weight management solutions.
C.J. Stroud Game-Time Decision vs Seahawks
Houston Texans fans hold their breath as rookie sensation C.J. Stroud's availability against Seattle Seahawks hangs in balance. Latest injury update and potential replacements revealed.
Diggs lists $4M Texas home amid concussion, trade rumors
Dallas Cowboys cornerback Trevon Diggs puts his luxurious $4 million Texas home on the market while missing Week 7 with concussion, fueling intense NFL trade rumors ahead of deadline.
Page 2 of 2